Developing useful highly active antiretroviral therapy adherence measures for India: the Prerana study
Ekstrand, M.L.; Chandy, S.; Heylen, E.; Steward, W.; Singh, G.
Journal of Acquired Immune Deficiency Syndromes 53(3): 415-416
2010
ISSN/ISBN: 1944-7884 PMID: 20190588 DOI: 10.1097/qai.0b013e3181ba3e4eDocument Number: 210141
Document emailed within 0-6 h
Related Documents
Saha, R.; Saha, I.; Sarkar, A.P.; Das, D.K.; Misra, R.; Bhattacharya, K.; Roy, R.N.; Bhattacharya, A. 2014: Adherence to highly active antiretroviral therapy in a tertiary care hospital in West Bengal, India Singapore Medical Journal 55(2): 92-98Dworkin, M.S.; Douglas, G.W.; Sabitha Rani, G.P.; Chakraborty, A. 2016: Adherence to highly active antiretroviral therapy in Hyderabad, India: barriers, facilitators and identification of target groups International Journal of Std and Aids 27(3): 186-195
Mohammadpour, A.; Yekta, Z.P.; Nikbakht Nasrabadi, A.R. 2010: HIV-infected patients' adherence to highly active antiretroviral therapy: a phenomenological study Nursing and Health Sciences 12(4): 464-469
Venkatesh, K.K.; Srikrishnan, A.K.; Mayer, K.H.; Kumarasamy, N.; Raminani, S.; Thamburaj, E.; Prasad, L.; Triche, E.W.; Solomon, S.; Safren, S.A. 2010: Predictors of nonadherence to highly active antiretroviral therapy among HIV-infected South Indians in clinical care: implications for developing adherence interventions in resource-limited settings Aids Patient Care and Stds 24(12): 795-803
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Sulaiman, M.M.; Shettima, J.; Ummate, I.; Arogundade, F.A.; Yusuph, H.; Nwankwo, E.; Sanusi, A.A.; Akinsola, A. 2022: Comparative Evaluation of Prevalence, Risk Factors, and Pathologic Features of Kidney Disease in Highly Active Antiretroviral Therapy-Naive and Highly Active Antiretroviral Therapy-Experienced Patients at a Tertiary Health Facility in Maiduguri, Northeastern Nigeria Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 33(1): 72-79
Harvey, K.M.; Carrington, D.; Duncan, J.; Figueroa, J.P.; Hirschorn, L.; Manning, D.; Jackson, S. 2008: Evaluation of adherence to highly active antiretroviral therapy in adults in Jamaica West Indian Medical Journal 57(3): 293-297
Nelwan, E.J. 2014: Adherence to highly active antiretroviral therapy (HAART) in HIV/AIDS patient Acta Medica Indonesiana 46(4): 273-274
Pearson, C.R.; Micek, M.; Simoni, J.M.; Matediana, E.; Martin, D.P.; Gloyd, S. 2006: Modified directly observed therapy to facilitate highly active antiretroviral therapy adherence in Beira, Mozambique. Development and implementation Journal of Acquired Immune Deficiency Syndromes 43(Suppl 1): S134-S141
Olisah, V.O.; Baiyewu, O.; Sheikh, T.L. 2010: Adherence to highly active antiretroviral therapy in depressed patients with HIV/AIDS attending a Nigerian university teaching hospital clinic African Journal of Psychiatry 13(4): 275-279
Ochieng, W.; Kitawi, R.C.; Nzomo, T.J.; Mwatelah, R.S.; Kimulwo, M.J.; Ochieng, D.J.; Kinyua, J.; Lagat, N.; Onyango, K.O.; Lwembe, R.M.; Mwamburi, M.; Ogutu, B.R.; Oloo, F.A.; Aman, R. 2015: Implementation and Operational Research: Correlates of Adherence and Treatment Failure Among Kenyan Patients on Long-term Highly Active Antiretroviral Therapy Journal of Acquired Immune Deficiency Syndromes 69(2): E49-E56
Afolabi, B.A.; Afolabi, M.O.; Afolabi, A.A.; Odewale, M.A.; Olowookere, S.A. 2013: Roles of family dynamics on adherence to highly active antiretroviral therapy among people living with HIV/AIDS at a tertiary hospital in Osogbo, south-west Nigeria African Health Sciences 13(4): 920-926
Oyugi, J.H.; Byakika-Tusiime, J.; Charlebois, E.D.; Kityo, C.; Mugerwa, R.; Mugyenyi, P.; Bangsberg, D.R. 2004: Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting Journal of Acquired Immune Deficiency Syndromes 36(5): 1100-1102
Lal, V.; Kant, S.; Dewan, R.; Rai, S.K.; Biswas, A. 2010: A two-site hospital-based study on factors associated with nonadherence to highly active antiretroviral therapy Indian Journal of Public Health 54(4): 179-183
Bandyopadhyay, D.; Basu, A.K.; Mandal, S.K.; Bandyopadhyay, R.; Pal, S.K.; Chakraborty, P.P.; Bose, S. 2004: Glycaemic consequences of HIV and highly active antiretroviral therapy: a pilot study and review of literature Journal of the Indian Medical Association 102(8): 453-456
Okome-Nkoumou, M.; Guiyedi, V.; Ondounda, M.; Efire, N.; Clevenbergh, P.; Dibo, M.; Dzeing-Ella, A. 2014: Opportunistic diseases in HIV-infected patients in Gabon following the administration of highly active antiretroviral therapy: a retrospective study American Journal of Tropical Medicine and Hygiene 90(2): 211-215
Piloya, T.; Bakeera-Kitaka, S.; Kekitiinwa, A.; Kamya, M.R. 2012: Lipodystrophy among HIV-infected children and adolescents on highly active antiretroviral therapy in Uganda: a cross sectional study Journal of the International Aids Society 15(2): 17427
Tesfaye, Z.; Enawgaw, B. 2014: Prevalence of anemia before and after initiation of highly active antiretroviral therapy among HIV positive patients in Northwest Ethiopia: a retrospective study Bmc Research Notes 7: 745
Tan, R.; Westfall, A.O.; Willig, J.H.; Mugavero, M.J.; Saag, M.S.; Kaslow, R.A.; Kempf, M.C. 2008: Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy Journal of Acquired Immune Deficiency Syndromes 47(5): 553-558